Functional genomics and the development of pathogenesis-targeted therapies for Kaposi's sarcoma
- PMID: 16013955
- DOI: 10.1517/14622416.6.3.235
Functional genomics and the development of pathogenesis-targeted therapies for Kaposi's sarcoma
Abstract
Kaposi's sarcoma (KS) is a multifocal angioproliferative disorder affecting the skin, mucosa and viscera of individuals infected with human herpesvirus-8 (HHV-8; also Kaposi's sarcoma-associated herpesvirus [KSHV]). KS is the most common neoplasm in AIDS patients; the clinical outcome of AIDS-KS is significantly improved by highly active antiretroviral therapy (HAART). However, in Africa, where the severest manifestations of KS occur, there is limited access to these and other effective but expensive drugs. Here we present a review of current efforts to identify novel therapeutic targets for the treatment of KS using functional genomics, with recommendations regarding the development of economically feasible treatments for use in Africa.
Similar articles
-
Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042.J Clin Oncol. 2014 Feb 10;32(5):402-8. doi: 10.1200/JCO.2012.48.6365. Epub 2013 Dec 30. J Clin Oncol. 2014. PMID: 24378417 Free PMC article. Clinical Trial.
-
A functional genomics approach to Kaposi's sarcoma.Ann N Y Acad Sci. 2002 Dec;975:180-91. doi: 10.1111/j.1749-6632.2002.tb05951.x. Ann N Y Acad Sci. 2002. PMID: 12538164
-
Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.AIDS. 2007 Jun 19;21(10):1245-52. doi: 10.1097/QAD.0b013e328182df03. AIDS. 2007. PMID: 17545700 Clinical Trial.
-
Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.Expert Rev Anticancer Ther. 2002 Apr;2(2):193-200. doi: 10.1586/14737140.2.2.193. Expert Rev Anticancer Ther. 2002. PMID: 12113241 Review.
-
Viruses in the pathogenesis of Kaposi's sarcoma--a review.Biochem Mol Med. 1996 Jun;58(1):1-12. doi: 10.1006/bmme.1996.0025. Biochem Mol Med. 1996. PMID: 8809339 Review.
Cited by
-
Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi's sarcoma and P. falciparum malaria.Front Microbiol. 2013 Mar 12;4:35. doi: 10.3389/fmicb.2013.00035. eCollection 2013. Front Microbiol. 2013. PMID: 23487416 Free PMC article.
-
Propranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression.J Virol. 2015 Nov;89(21):11144-9. doi: 10.1128/JVI.01569-15. Epub 2015 Aug 12. J Virol. 2015. PMID: 26269192 Free PMC article.
-
Role of haem oxygenase-1 in microbial host defence.Cell Microbiol. 2009 Feb;11(2):199-207. doi: 10.1111/j.1462-5822.2008.01261.x. Epub 2008 Nov 3. Cell Microbiol. 2009. PMID: 19016784 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical